South Korea fines Novartis over kickbacks, suspends sales of some drugs

SEOUL (Reuters) - South Korea said it has fined Swiss drugmaker Novartis 200 million won ($174,937) and temporarily banned sales of some of its drugs for paying kickbacks to doctors in exchange for recommending the company's drugs.

South Korea fines Novartis over kickbacks, suspends sales of some drugs
Read More


Bagikan Berita Ini